BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/23/2025 6:49:00 AM | Browse: 167 | Download: 520
Publication Name World Journal of Clinical Oncology
Manuscript ID 111537
Country India
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Letter to the Editor
Article Title Are we overestimating success of salvage hepatectomy in unresectable hepatocellular carcinoma?
Manuscript Source Unsolicited Manuscript
All Author List Babu Lal Meena and Deepti Sharma
ORCID
Author(s) ORCID Number
Babu Lal Meena http://orcid.org/0000-0002-7019-1020
Deepti Sharma http://orcid.org/0000-0002-9911-3384
Funding Agency and Grant Number
Corresponding Author Deepti Sharma, Associate Professor, Department of Radiation Oncology, Institute of liver and Biliary Sciences, Vasant Kuunj, New Delhi, India, New Delhi 110070, India. drdeeptisharma16@gmail.com
Key Words Salvage hepatectomy; Pathological complete response; Tyrosine kinase inhibitors; Unresectable hepatocellular carcinoma; Locoregional modalities
Core Tip The primary treatment modality for advanced hepatocellular carcinoma is systemic therapy. However, downstaging can be done with use of locoregional modalities like trans arterial chemoembolization, transarterial radioembolization, radiation therapy etc. along with systemic therapies (tyrosine kinase inhibitors and immune checkpoint inhibitor) followed by salvage surgery results in improved survival with limited adverse effects, if patient selection is judicially made.
Publish Date 2025-09-23 06:49
Citation

Meena BL, Sharma D. Are we overestimating success of salvage hepatectomy in unresectable hepatocellular carcinoma? World J Clin Oncol 2025; 16(9): 111537

URL https://www.wjgnet.com/2218-4333/full/v16/i9/111537.htm
DOI https://dx.doi.org/10.5306/wjco.v16.i9.111537
Full Article (PDF) WJCO-16-111537-with-cover.pdf